Novo Nordisk India launches world’s first and only GLP-1 RA, oral semaglutide
Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach
Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
The surgery was helmed by Prof. Dr. Vishwanath Pai, Sr. Consultant, Department of Minimally Invasive Surgery, Prashanth Hospitals, Velachery
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
The division is expected to grow to over a 100-member strong team by 2022
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
Subscribe To Our Newsletter & Stay Updated